NorthWest Biotherapeutics Inc (NWBO)

[OncoJock]

Update on Headwinds Slowing CDMO Business at CRL

Here's a detailed and timely look at how Charles River Laboratories (CRL) is encountering difficulties integrating its recent acquisitions of 2 contract development and manufacturing organizations (CDMOs), namely Cognate and Vigene, causing CRL to miss earnings targets, at least temporarily. CRL stock price is down about 10% this morning.

https://ir.criver.com/static-files/9a616c57-5c55-4bcc-a2fb-b46dd0f50630

See especially pages 10, 11, and 12.

Any comments from biosectinvestor, ATLnsider, flipper44, or other savvy iHubbers on how CRL's difficulties may, or may not, be relevant to us as NWBO shareholders?